DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment


Cardiology Homepage

FDA gives nod to Stryker’s Neuroform Atlas Stent System Treats wide neck, intracranial, and saccular aneurysms

Neusoft's NueViz Prime 128-slice CT scores FDA clearance High-speed system may improve imaging in trauma, pediatrics and cardiac cases

Updated guidelines recommend use of S-ICDs for patients with ventricular arrhythmia Call to action for physicians

Konica Minolta signs group purchasing agreement with Premier for the Exa platform The three-year deal brings special pricing to 3,900 hospitals

A look at pheno-mapping in cardiovascular imaging Transforms data from cardiac imaging into an 'imaging phenotype'

Global interventional X-ray market to be worth over $3 billion in 2021 Low-volume facilities are purchasing new systems

Despite Brexit, ESC Congress will return to London in 2021 Decision based in large part on Mayor's active lifestyle initiative

In Mexico, a call for sterilized, used pacemakers as implants in new study An alternative for those who cannot afford new pacemakers

Image-guided Harpoon device safe and effective for mitral valve heart repair: study Less invasive than conventional mitral valve surgery

Global cardiac pacemaker market to almost double by 2023 As people live longer, cardiovascular disease becomes more prominent

CVR Medical's
Carotid Stenotic Scan device

CVR Medical’s Carotid Stenotic Scan device shows promise in clinical trials

by Lauren Dubinsky , Senior Reporter
CVR Medical’s Carotid Stenotic Scan device is showing promise for replacing CT imaging as a cheaper tool for detecting stroke.

Late last week, a research team from Thomas Jefferson University released data from its clinical trials that confirmed the CSS device’s value and efficiency.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory

“From a clinical standpoint … the most important point is likely that the CSS, in a statistical sense, is very specific,” Phillip J. Bendick, Ph.D., stated. “Nearly all of the tested patients that had carotid artery stenosis were identified without an ‘overread,’ an important measure which allows doctors to recommend steps for further care with confidence.”

Blood flows through the carotid arteries and generates wave patterns that are shaped and altered by any irregularities on the inner artery walls. The CSS device captures the wave patterns and evaluates them with patented algorithms in order to determine a patient’s risk of stroke.

Over 795,000 Americans suffer a stroke every year and about 140,000 of those cases are fatal, according to the Centers for Disease Control and Prevention. In addition, the CDC Foundation reported that stroke and heart diseases cost the U.S. almost $1 billion per day in medical costs and lost productivity.

The cost associated with diagnosing stroke is also high, with the price of CT systems reaching up to $2.5 million and exams ranging from $825 to $4,800, according to New Choice Health.

The CSS device has the potential to cut those costs, since each unit is targeted to cost about $49,000. It also doesn’t require a certified technician to operate it and an exam can be completed in a few minutes.

CVR Medical is currently entering the clinical phase of the development process. The final market version of the CSS device is being assembled and prepared for pivotal trials, which will serve as the basis for FDA clearance.

At the end of August, CVR Medical signed a letter of intent with Canon Virginia Inc., a domestic manufacturing subsidiary of Canon U.S.A. Inc. Once the device receives regulatory approval, Canon will start manufacturing it at its facilities.

CVR Medical is also involved in other manufacturing deals, including a partnership with ADCO Circuit that was announced in March. The company will be the exclusive provider of CSS custom circuit boards for its sensors.

“Internally, in discussions with our engineering and scientific development teams, indications are that we expect the device to improve markedly above the 85% sensitivity level,” Peter Bakema, CEO of CVR Medical, said in a statement. “This, coupled with the expansion of trials for a larger sample size, continues to put us in position for a successful submission to the FDA.”

Back to HCB News
  Pages: 1

Cardiology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2017, Inc.